Stryker Corporation (SYK) Cash Flow Statement

NYSE: SYKOperating cash, capex, free cash flow and buybacks.

Where SYK’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
$5.04B
+18.9% vs 2024
Capital expenditures
$761.0M
3.0% of revenue
Free cash flow
$4.28B
17.1% margin
Returned to shareholders
$1.43B
33% of free cash flow
Change in cash
$359.0M
cash at year-end $4.01B
Cash from operations: $5.04BCash from operations$5.04BInvestments (net): $750.0MInvestments (net)$750.0MBorrowing: $1.58BBorrowing$1.58BCurrency & other: $68.0MCurrency & other$68.0MAcquisitions & other: $4.86BAcquisitions & other$4.86B · 65%Dividends: $1.28BDividends$1.28B · 17%Capital expenditures: $761.0MCapital expenditures$761.0M · 10%Added to cash: $359.0MAdded to cash$359.0M · 5%Share buybacks, Other financing: $182.0MOther uses$182.0M · 2%$7.44B
Cash from operations
$5.04B
Capital expenditures
−$761.0M
Investments (net)
+$750.0M
Acquisitions & other
−$4.86B
Dividends
−$1.28B
Share buybacks (net)
−$149.0M
Net borrowing (repayment)
+$1.58B
Other financing
−$33.0M
Currency & other
+$68.0M
Change in cash
$359.0M

Drawn to scale: where the cash came from and how it was used. Hover for values.

SYK operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

SYK cash flow trends, 2016–2025

Stryker Corporation cash flow trends
MetricTrendThenLatestChange
Operating cash flow$1.92B2016$5.04B2025+11.4%/yr
Capital expenditures$490.0M2016$761.0M2025+5.0%/yr
Free cash flow$1.43B2016$4.28B2025+13.0%/yr
Free cash flow margin12.6%201617.1%2025+4.5 pts
Operating cash flow / net income1.1620161.552025+0.39
Stock-based compensation$97.0M2016$243.0M2025+10.7%/yr
Dividends paid$568.0M2016$1.28B2025+9.5%/yr
Share buybacks (net)$13.0M2016$149.0M2025+31.1%/yr
Capex / revenue4.3%20163.0%2025−1.3 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

SYK cash flow by activity

OperatingInvestingFinancingChange in cash

SYK net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

SYK cash flow statement

Stryker Corporation annual cash flow statement
2025202420232022202120202019201820172016
Operating activities
Net income$3.25B$2.99B$3.17B$2.36B$1.99B$1.60B$2.08B$3.55B$1.02B$1.65B
Depreciation & amortization$1.19B$1.05B$1.03B$998.0M$990.0M$812.0M$778.0M$723.0M$642.0M$546.0M
Stock-based compensation$243.0M$229.0M$205.0M$168.0M$171.0M$142.0M$127.0M$119.0M$113.0M$97.0M
Change in working capital−$373.0M−$683.0M−$500.0M−$732.0M$279.0M$866.0M−$670.0M−$1.67B−$103.0M−$381.0M
Other non-cash items$735.0M$653.0M−$187.0M−$168.0M−$171.0M−$142.0M−$127.0M−$119.0M−$113.0M$6.0M
Cash from operating activities$5.04B$4.24B$3.71B$2.62B$3.26B$3.28B$2.19B$2.61B$1.56B$1.92B
Investing activities
Capital expenditures−$761.0M−$755.0M−$575.0M−$588.0M−$525.0M−$487.0M−$649.0M−$572.0M−$598.0M−$490.0M
Investments (net)$750.0M−$3.00B−$972.0M−$2.92B−$859.0M$7.0M−$5.0M$168.0M−$183.0M$634.0M
Acquisitions & other investing−$4.86B$755.0M$585.0M$588.0M$525.0M−$4.22B−$801.0M−$2.45B−$832.0M−$4.33B
Cash from investing activities−$4.87B−$3.00B−$962.0M−$2.92B−$859.0M−$4.70B−$1.46B−$2.86B−$1.61B−$4.19B
Financing activities
Dividends paid−$1.28B−$1.22B−$1.14B−$1.05B−$950.0M−$863.0M−$778.0M−$703.0M−$636.0M−$568.0M
Share repurchases & issuance (net)−$149.0M−$195.0M−$155.0M−$122.0M−$114.0M−$110.0M−$307.0M−$300.0M−$230.0M−$13.0M
Net borrowing (repayment)$1.58B$940.0M−$277.0M$472.0M−$1.15B$989.0M$1.29B$2.46B$299.0M$2.91B
Shares issued$0$0$0$0$0$0$0$0$0$0
Other financing−$33.0M−$51.0M−$23.0M−$48.0M−$148.0M−$27.0M−$205.0M−$124.0M−$227.0M−$73.0M
Cash from financing activities$113.0M−$525.0M−$1.59B−$749.0M−$2.37B−$11.0M$3.0M$1.33B−$794.0M$2.26B
Summary
Net change in cash$359.0M$681.0M$1.13B−$1.10B$1.0M−$1.39B$721.0M$1.07B−$774.0M−$63.0M
Cash at end of period$4.01B$3.65B$2.97B$1.84B$2.94B$2.94B$4.34B$3.62B$2.54B$3.32B
Free cash flow$4.28B$3.49B$3.14B$2.04B$2.74B$2.79B$1.54B$2.04B$961.0M$1.43B
Free cash flow margin17.1%15.4%15.3%11.0%16.0%19.4%10.4%15.0%7.7%12.6%
Capex / revenue3.0%3.3%2.8%3.2%3.1%3.4%4.4%4.2%4.8%4.3%
Operating cash flow / net income1.551.421.171.111.642.051.050.731.531.16

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

SYK cash generation

In fiscal 2025 (ended December 31, 2025), Stryker generated $5.0 billion of cash from operations (up 18.9%) and spent $761.0 million on capital expenditures, leaving free cash flow of $4.3 billion, 17.1% of revenue. It returned $1.4 billion to shareholders through dividends ($1.3 billion) and net share buybacks ($149.0 million). Cash and equivalents rose by $359.0 million over the year.

Related: SYK income statement, SYK balance sheet, SYK dividend history. See the SYK stock overview for the latest quote and news.

SYK cash flow FAQ

What is Stryker's free cash flow?

Stryker's free cash flow was $4.3 billion in fiscal 2025: $5.0 billion of operating cash flow minus $761.0 million of capital expenditures It was $3.5 billion a year earlier..

How much cash does Stryker generate from operations?

Stryker generated $5.0 billion of cash from operating activities in fiscal 2025, 1.55 times its net income of $3.2 billion.

How much does Stryker spend on capital expenditures?

Stryker spent $761.0 million on capital expenditures in fiscal 2025, 3.0% of revenue, compared with $755.0 million the year before.

How much stock does Stryker buy back?

Stryker spent $149.0 million on net share repurchases in fiscal 2025.

How much does Stryker pay in dividends?

Stryker paid $1.3 billion in dividends in fiscal 2025, 30.0% of free cash flow.

Medical Devices: cash flow